首页 | 本学科首页   官方微博 | 高级检索  
检索        

参脉康胶囊对冠心病不稳定型心绞痛患者血清P-选择素的影响
引用本文:袁先琢.参脉康胶囊对冠心病不稳定型心绞痛患者血清P-选择素的影响[J].中国医药导报,2011,8(20):122-123.
作者姓名:袁先琢
作者单位:安徽省滁州中西医结合医院,安徽滁州,239001
摘    要:目的:观察参脉康胶囊对冠心病不稳定型心绞痛患者血清P-选择素水平的影响。方法:将纳入的70例冠心病不稳定型心绞痛患者随机分为治疗组35例(参脉康胶囊+常规药物),对照组35例(常规药物)。疗程均为28 d。观察、对比治疗前后血清P-选择素水平的变化。结果:治疗后治疗组P-选择素水平,与对照组比较,差异有统计学意义(P〈0.05)。结论:参脉康胶囊对冠心病不稳定型心绞痛疗效肯定,可有效地降低冠心病不稳定型心绞痛患者血浆P-选择素水平,抑制血小板聚集和炎症反应。

关 键 词:冠心病不稳定型心绞痛  P-选择素  参脉康胶囊

Influence on P-selectin of the patients with coronary heart disease unstable angina by Shenmaikang Capsule
YUAN Xianzhuo.Influence on P-selectin of the patients with coronary heart disease unstable angina by Shenmaikang Capsule[J].China Medical Herald,2011,8(20):122-123.
Authors:YUAN Xianzhuo
Institution:YUAN Xianzhuo Chuzhou Hopital of TCM Combined with Western Medicine,Anhui Province,Chuzhou 239001,China
Abstract:Objective:To observe the reference of Shenmaikang Capsule to P-selectin levels in serum of patients with coronary heart disease unstable angina.Methods:A total of 70 patients with coronary heart disease unstable angina were randomly divided into treatment group 35 cases(Shenmaikang Capsule + conventional drugs),the control group 35 cases(conventional drugs).Course of treatment was 28 days.The change of P-selectin serum levels before and after treatment were observed and compared.Results:After treatment,leve...
Keywords:Coronary heart disease unstable angina  P-selectin  Shenmai capsule  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号